Cardiovascular diseases (CVD) and mortality remain significant public health challenges, especially among middle-aged and older adults. However, their relationship with Uric Acid to High-Density Lipoprotein Cholesterol Ratio (UHR) has not been extensively studied in the US population. This study aimed to examine these associations in adults aged ≥ 40 based on the National Health and Nutrition Examination Survey (NHANES) 1999–2018. 29,742 participants’ data in NHANES between 1999 and 2018 were retrospectively analyzed. Multivariable logistic regression, Cox proportional hazards models, restricted cubic spline (RCS) analyses, and subgroup analyses were used to assess the associations between UHR and various CVD outcomes. Among the participants, 4,505 (15.15%) reported a history of CVD. A positive association was observed between UHR and the risk of total CVD, including coronary heart disease, heart attack, heart failure, angina pectoris, and stroke (Pall < 0.05). UHR was associated with increased risks of all-cause mortality (HR = 1.02, 95% CI: 1.02–1.03) and CVD-specific mortality (HR = 1.03, 95% CI: 1.02–1.05). UHR had a linear dose-response relationship with CVD and a nonlinear relationship with all-cause mortality by RCS analyses. Subgroup analyses confirmed that these associations remained stable across different groups. The findings highlight UHR as a significant predictor of CVD risk and mortality in middle- and older-age adults. Given its strong association with adverse health outcomes, UHR can be a valuable indicator in facilitating the early identification of individuals at elevated cardiovascular risk.
Background: Gastric cancer (GC) is a highly aggressive malignancy with a poor prognosis, closely linked to the tumor microenvironment (TME). Emerging evidence highlights the critical role of gastric cancer-associated mesenchymal stem cells (GC-MSCs) in recruiting neutrophils and facilitating neutrophil extracellular traps (NETs) formation, thereby remodeling the tumor microenvironment (TME) and promoting tumor progression, immune modulation, and metastasis. Methods: This study integrated single-cell RNA sequencing (scRNA-seq), Mendelian randomization (MR), and functional enrichment analyses to uncover the molecular underpinnings of GC. Transcriptomic data from public databases, including TCGA and GEO, were analyzed to explore cellular heterogeneity and the influence of NETs within the TME. MR analysis was conducted to establish causal relationships between key NET-related genes and GC. We integrated scRNA-seq, MR, and functional enrichment analyses to systematically dissect the roles of GC-MSCs and NETs in reshaping the tumor microenvironment. Results: scRNA-seq identified 12 distinct cell types in the TME, with significantly elevated NET scores associated with GC-MSCs in the disease group. Functional enrichment analyses revealed that NET-associated marker genes were enriched in pathways such as oxidative phosphorylation and cytoplasmic translation. MR analysis confirmed EIF1 and RPS12 as key genes with causal links to GC progression, demonstrating robust associations with immune cell infiltration and critical signaling pathways. Additionally, transcriptional regulation analysis identified motifs and transcription factors governing these genes, while GSEA highlighted their involvement in pathways such as ribosome biogenesis and focal adhesion. Conclusion: This study elucidates the intricate interplay between GC-MSCs, NETs, and the immune microenvironment, offering novel insights into GC pathogenesis and potential therapeutic targets. EIF1 and RPS12 emerge as promising candidates for precision medicine, with broader implications for NET-related cancer research.
1 November 2024 in Clinical Interventions in Aging